niaaa: current and future priorities · primary goal of coga: to find and understand genes that...
TRANSCRIPT
NIAAA: Current and Future Priorities
George F. Koob, Ph.D. Director
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
Cost and Scope of Addiction
Alcohol Issues Across the Lifespan
• NIAAA supports research to study how alcohol can affect health and well-being at various stages of life.
Alcohol
Prenatal Alcohol
Exposure
Binge Drinking Organ
Damage
Medication Interactions
Alcohol Dependence Alcoholic
Family Environment
Lifespan Transcending Themes • Neurobiology • Metabolism • Genetics • Epigenetics • Epidemiology • Health Services Research
Special Thanks to Dr. Ken Warren
Acting Director NIAAA 2008- 2014
Deputy Director NIAAA
Czar of Fetal Alcohol Syndrome Portfolio
NIAAA Extramural Grant Portfolio, FY 2013 Total Funding $319,759,079 n=955
(sequestration)
• International Research • Mechanisms of
Behavior Change • Underage Drinking
Treatment (n=102)
$15,428,018
$42,571,054 $32,443,946
$31,428,670
$74,364,840
$123,522,551
Health Services (n=32)
Prevention (n=84)
Epidemiology (n=95)
Metabolism & Health Effects (n=239)
Neuroscience & Behavior (n=403)
NIAAA Trans-Divisional Research Emphasis Areas
• Biomarkers • Fetal Alcohol Spectrum
Disorders • Genes and Environment
• Health Disparities • HIV and AIDS • Systems Biology • Medications Development
1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders
2. Underage and College Drinking
3. Neurobiology of Alcoholism
4. Genetics of Alcoholism
5. Treatment of Alcoholism
6. . Alcoholic Liver Disease
7. HIV/AIDS
Current NIAAA Priority Programs
1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders
2. Underage and College Drinking
3. Neurobiology of Alcoholism
4. Genetics of Alcoholism
5. Treatment of Alcoholism
6. . Alcoholic Liver Disease
7. HIV/AIDS
Current NIAAA Priority Programs
• Improve diagnostic capabilities to determine the full prevalence of Fetal Alcohol Spectrum Disorder (FASD) and identify women and children in need of care and services
• Improve detection of risk drinking during pregnancy by developing new biomarkers
• Given the subtlety of FAS facial deficits – improve the acumen for FAS facial recognition through 3-D photography and computer analysis
• Refine our understanding of the complexities in the neurobehavioral phenotype associated with FASD
• Prevent and/or ameliorate the effects of FASD through nutritional supplementations, pharmacology, or enhanced CNS stimulation
FASD Research Research Challenges:
• Consortium of approximately 8 Principal Investigators and many Co-investigators
• Animal and human research
• International project with study sites in U.S., South Africa, Europe, Asia
• Research from CIFASD was critical to acceptance by APA of a new diagnostic category for Neurobehavioral Disorder: Prenatal Alcohol Exposed
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (FASD) – ongoing since 2003 :
FASD Consortia
Prenatal Alcohol, Sudden Infant Death Syndrome (SIDS)), and Stillbirth (PASS)
• Joint initiative with NICHD and Deafness Institute • On-going since 2003
• Study sites in: • South and North Dakota – population Caucasian and American
Indian • South Africa – mixed ancestry population known as Cape Coloured
• Major dependent variable is alcohol, secondary tobacco and other drugs (e.g., methamphetamine); study is powered on rarest outcome, i.e., SIDS
1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders
2. Underage and College Drinking
3. Neurobiology of Alcoholism
4. Genetics of Alcoholism
5. Treatment of Alcoholism
6. . Alcoholic Liver Disease
7. HIV/AIDS
Current NIAAA Priority Programs
• Complementing N-CANDA, NADIA uses animal models to assess the effects of adolescent alcohol exposure on the adult brain.
• Unlike studies with human adolescents, animal studies can control environmental factors and administer alcohol during adolescence.
Neurobiology of Adolescent Drinking in Adulthood (NADIA) – Animal Studies
Objectives: • Study effects of alcohol exposure on trajectory of adolescent
brain development in the context of development
• Examine dose, duration, and timing effects of alcohol exposure
• Determine what structural and functional anomalies are the result of alcohol exposure and what predates, and may predict, heavy alcohol use
• Identify neuroimaging and/or neurocognitive brain markers that predict onset of AUD and other psychopathology
National Consortium on Alcohol and Neurodevelopment in Adolescence
Ken Sher (SAB)
Andrea Hussong (SAB)
Raquel Gur (SAB)
Susan Tapert Sandra Brown
Mike DeBellis
Duncan Clark Bonnie Nagel
Sites Advisors Collabora0ons
OHSU Portland
Dolf Pfefferbaum Torsten Rohlfing
Ian Colrain Fiona Baker
Duke
PiLsburgh SRI/Stanford
UC San Diego
Robert Zucker (SAB)
Supported by: NIAAA NIMH NICHD NIDA
• In response to a request from NIAAA’s College Presidents Working Group, NIAAA engaged top researchers in the field to develop an interactive, user-friendly, print and online “decision support system” to help colleges and universities select appropriate strategies to meet their alcohol intervention goals.
• The tool will allow college presidents and staff to review the strategies they are already using as well as explore others that may serve them better.
• Users will be able to search for strategies according to intervention level (e.g., individual, group, campus-wide, community) and evaluate other factors, such as effectiveness, barriers and costs, affecting implementation
• We envision that much like online shopping applications, the online tool will allow users to select a set of strategies for side-by-side comparisons
College Drinking College Drinking Intervention Matrix – Coming Soon
1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders
2. Underage and College Drinking
3. Neurobiology of Alcoholism
4. Genetics of Alcoholism
5. Treatment of Alcoholism
6. . Alcoholic Liver Disease
7. HIV/AIDS
Current NIAAA Priority Programs
Conceptual Framework for Neurobiological Bases of the Transition to Excessive Drinking
• An 11 site multidisciplinary consortium devoted to identifying molecular, cellular, and behavioral neuroadaptations that occur in the brain due to alcohol exposure that contribute to excessive alcohol consumption in some individuals.
• The current objective of INIA is to confirm previously identified gene targets and identify druggable targets that are the most promising for medications development for the treatment of alcoholism.
• This will be achieved using: ⁻ the extensive INIA genomics data set ⁻ the INIA mutant mouse and behavioral testing cores ⁻ INIA electrophysiology expertise
Integrative Neuroscience Initiative on Alcoholism (INIA)
NeuroadaptaQon
• A cooperative consortium of 15 Principal Investigators from 9 academic institutions across the US.
• The INIA stress consortium uses a state-of-the art translational approach (mice, monkeys and humans) to:
Integrative Neuroscience Initiative on Alcoholism (INIA)
INIA-‐Stress
Ø understand the interaction of genetic variation and stress on the promotion of excessive drinking Ø identify novel, effective and tailored treatment
strategies for alcoholism.
Primary Goal of COGA: To find and understand genes that affect the risk for the development of alcoholism and related disorders. This is being accomplished through linkage, GWAS, and whole-exome sequencing studies as well as gene expression and epigenetic studies.
The COGA family pedigrees are densely affected with alcoholism containing at least 2 alcohol-dependent first-degree relatives in addition to an alcohol dependent proband.
Participants from 9 US sites
Collaborative Study on the Genetics of Alcoholism (COGA)
1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders
2. Underage and College Drinking
3. Neurobiology of Alcoholism
4. Genetics of Alcoholism
5. Treatment of Alcoholism
6. Alcoholic Liver Disease
7. HIV/AIDS
Current NIAAA Priority Programs
• Mission: To improve the care and treatment of those affected by AUD, high-risk drinking, and alcohol-related medical disorders by supporting the development of effective and safe medications that are accepted and used by clinicians and patients.
• Overall Goal: Translate promising medications from discovery to preclinical and human clinical testing to real-world effectiveness and implementation studies.
NIAAA Medications Development Program for Alcohol Use Disorder (AUD), High-Risk
Drinking, and Alcohol-Related Medical Disorders
SCREENING MODELS
VALIDATION PROCESS: BIDIRECTIONAL INTEGRATION
Molecular Targets
Animal Models
Human Laboratory
Models
Clinical Trials
PURPOSE
• Bridge gap between preclinical studies and expensive, time-consuming Phase 3 trial
• Quick turnaround (1½ years)
• Access to many CNS compounds of pharmaceutical companies
• Ability to deal with intellectual property
• Study design flexibility
NIAAA Clinical Investigation Group (NCIG)
Network of Sites for Proof of Concept Trials
1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders
2. Underage and College Drinking
3. Neurobiology of Alcoholism
4. Genetics of Alcoholism
5. Treatment of Alcoholism
6. . Alcoholic Liver Disease
7. HIV/AIDS
Current NIAAA Priority Programs
Building a New Research Program for Alcoholic Hepatitis
Create a rich and fertile
environment for new and
collaborations
Understand the pathogenesis and identify
new molecular targets
Identify best therapeutic regiments based on patients’ risk factors, pathogenesis,
prognosis
The Veterans Aging Cohort Study (VACS) is a prospective, observational cohort study of HIV- positive and an age/race/site matched control group of HIV- negative veterans in care in the United States. The study's aim is to understand the role of comorbid medical and psychiatric disease in determining clinical outcomes in HIV infection. The study has a special focus on the role of alcohol use and abuse in determining clinical outcomes.
Veterans Aging Cohort Study (VACS)
1. Functional Merge: Co-morbidity, Co- training, Co- Prevention, Co- Treatment
2. Neurobiology of Intoxication
3. Sleep and Alcoholism
4. Post traumatic Stress Disorder
5. Standardization of Prevention Options for Middle and Secondary Schools
5. Standardization of Prevention Options for College Campuses
Future NIAAA Priority Programs
Collaborative Research on Addiction at NIH (CRAN)
Uber CRAN? National Longitudinal Study of Neurodevelopmental
Consequences of Substance Use
Study Aims: What is the impact of the sporadic versus the regular use of marijuana, alcohol, nicotine and other substances on the developing brain? What are the neurodevelopmental pathways that link adolescent substance use and pre-existing or emerging mental illnesses? What are the effects of multiple substances in combination? Partnering Agencies: The study will be led by the Collaborative Research on Addiction (CRAN) at NIH (National Institute on Drug Abuse [NIDA], National Institute on Alcohol Abuse and Alcoholism [NIAAA], and the National Cancer Institute [NCI]) in collaboration with the National Institute of Child Health and Human Development (NICHD) and potentially other Institutes (National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH)). We are also seeking partnership with other agencies (CDC, FDA, ONDCP) Study Design: The study will consist of a large representative cohort (i.e. approximately 10,000) youth that will be followed over a 10-year period, beginning before drug use is initiated and continuing into early adulthood.
1. FDA approval for medications for treatment of alcoholism
2. Implementation of effective behavioral treatments for alcoholism
3. Implementation of effective prevention strategies for adolescent drinking
4. Implementation of effective prevention strategies for drinking during pregnancy
5. Elimination of alcohol –related HIV pathology
6. Establishment of effective treatments for fetal alcohol spectrum disorder (FASD)
7. Development effective treatments for alcoholic liver disease
8. Appropriate treatment of co-morbidities associated with alcoholism
9. Successful recruitment of young investigators to the alcohol field, elimination of disparities in the alcohol field. Equal pay for women and minorities in the alcohol field
Where we want to be
Thank You! George F. Koob, Ph.D.
Director National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health